1. 29: Computer-Assisted Image Analysis of an Oral Cavity Squamous Cell Carcinoma Tissue Microarray. (September 2016) Authors: Lee, Sangjune; Cabanero, Michael; Hyrcza, Martin; Butler, Marcus; Liu, Fei-Fei; Hansen, Aaron; Huang, Shao Hui; Tsao, Ming; Song, Yuyao; Xu, Wei; Goldstein, David; Weinreb, Ilan; Bratman, Scott Journal: Radiotherapy and oncology Issue: Volume 120(2016)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 71. MGMT PROMOTER METHYLATION IS A PROGNOSTIC BIOMARKER IN EGFR MUTANT LUNG ADENOCARCINOMA WITH BRAIN METASTASES. (4th August 2020) Authors: Mamatjan, Yasin; Zuccato, Jeffrey; Moraes, Fabio; Cabanero, Michael; Shali, Wumairehan; Weiss, Jessica; Tsao, Ming; Aldape, Kenneth; Shepherd, Frances; Zadeh, Gelareh Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226. (May 2020) Authors: Juergens, Rosalyn A.; Hao, Desiree; Ellis, Peter M.; Tu, Dongsheng; Mates, Mihaela; Kollmannsberger, Christian; Bradbury, Penelope A.; Tehfe, Moustapha; Wheatley-Price, Paul; Robinson, Andrew; Bebb, Gwyn; Laskin, Janessa; Goffin, John; Hilton, John; Tomiak, Anna; Hotte, Sebastien; Goss, Glenwood ... Journal: Lung cancer Issue: Volume 143(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229). (16th August 2019) Authors: Chia, Stephen; Bedard, Phillipe L.; Hilton, John; Amir, Eitan; Gelmon, Karen; Goodwin, Rachel; Villa, Diego; Cabanero, Michael; Tu, Dongsheng; Tsao, Ming; Seymour, Lesley Journal: Oncologist Issue: Volume 24:Number 11(2019) Page Start: 1439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10271 (23rd January 2021) Authors: Lheureux, Stephanie; Cristea, Mihaela C; Bruce, Jeffrey P; Garg, Swati; Cabanero, Michael; Mantia-Smaldone, Gina; Olawaiye, Alexander B; Ellard, Susan L; Weberpals, Johanne I; Wahner Hendrickson, Andrea E; Fleming, Gini F; Welch, Stephen; Dhani, Neesha C; Stockley, Tracy; Rath, Prisni; Karakasis,... Journal: Lancet Issue: Volume 397:Issue 10271(2021) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases. (August 2020) Authors: Fares, Aline F.; Lok, Benjamin H.; Zhang, Tong; Cabanero, Michael; Lau, Sally C.M.; Stockley, Tracy; Patel, Devalben; Bradbury, Penelope A.; Sacher, Adrian; Yasufuku, Kazuhiro; Morash, Barbara A.; Sabatini, Peter J.B.; Nguyen, Lananhn N.; Leighl, Natasha B.; Tsao, Ming-Sound; Shepherd, Frances A.... Journal: Lung cancer Issue: Volume 146(2020) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD). Issue 2 (4th January 2023) Authors: Jung, Flora; Shapera, Shane; Cabanero, Michael; McInnis, Micheal; Fisher, Jolene Journal: Respirology case reports Issue: Volume 11:Issue 2(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BIOM-02. IDENTIFYING MGMT ALTERATIONS AS BIOMARKERS OF SURVIVAL IN LUNG ADENOCARCINOMA WITH BRAIN METASTASES. (9th November 2020) Authors: Mamatjan, Yasin; Zuccato, Jeffrey; Moraes, Fabio; Cabanero, Michael; Shali, Wumairehan; Weiss, Jessica; Tsao, Ming; Aldape, Kenneth; Shepherd, Frances; Zadeh, Gelareh Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer. (August 2020) Authors: Shi, Ruoshi; Filho, Sebastiao N. Martins; Li, Ming; Fares, Aline; Weiss, Jessica; Pham, Nhu-An; Ludkovski, Olga; Raghavan, Vibha; Li, Quan; Ravi, Deepti; Cabanero, Michael; Moghal, Nadeem; Leighl, Natasha B.; Bradbury, Penelope; Sacher, Adrian; Shepherd, Frances A.; Yasufuku, Kazuhiro; Tsao, Ming... Journal: Lung cancer Issue: Volume 146(2020) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BSCI-26. COMPARATIVE METHYLATION PROFILING OF EGFR MUTANT LUNG ADENOCARCINOMA AND PAIRED BRAIN METASTASIS. (12th August 2019) Authors: Mamatjan, Yasin; Zuccato, Jeffrey; Karimi, Shirin; Cabanero, Michael; Weiss, Jessica; Sorotsky, Hadas; Tsao, Ming; Shepherd, Frances; Aldape, Kenneth; Zadeh, Gelareh Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗